{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T08:23:09Z","timestamp":1773303789333,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T00:00:00Z","timestamp":1584489600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T00:00:00Z","timestamp":1584489600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s11239-020-02089-5","type":"journal-article","created":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T18:03:25Z","timestamp":1584554605000},"page":"837-843","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Experience of a 40-day (6\u00a0week) LMWH treatment for isolated distal deep vein thrombosis"],"prefix":"10.1007","volume":"50","author":[{"given":"Konstantinos","family":"Asonitis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekatherina","family":"Charvalos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cedric","family":"Hermans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,18]]},"reference":[{"issue":"10","key":"2089_CR1","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1056\/NEJMra072753","volume":"358","author":"VF Tapson","year":"2008","unstructured":"Tapson VF (2008) Acute pulmonary embolism. N Engl J Med 358(10):1037\u20131052","journal-title":"N Engl J Med"},{"issue":"6","key":"2089_CR2","doi-asserted-by":"publisher","first-page":"623","DOI":"10.21037\/cdt.2016.11.22","volume":"6","author":"JJ Farrell","year":"2016","unstructured":"Farrell JJ et al (2016) Incidence and interventions for post-thrombotic syndrome. Cardiovasc Diagn Ther 6(6):623\u2013631","journal-title":"Cardiovasc Diagn Ther"},{"issue":"8","key":"2089_CR3","doi-asserted-by":"publisher","first-page":"e217","DOI":"10.1161\/CIRCULATIONAHA.109.925651","volume":"121","author":"SR Vazquez","year":"2010","unstructured":"Vazquez SR, Kahn SR (2010) Postthrombotic syndrome. Circulation 121(8):e217\u2013e219","journal-title":"Circulation"},{"issue":"12","key":"2089_CR4","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1182\/blood-2013-12-512681","volume":"123","author":"C Kearon","year":"2014","unstructured":"Kearon C, Akl EA (2014) Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism. Blood 123(12):1794\u20131801","journal-title":"Blood"},{"issue":"6 Suppl","key":"2089_CR5","doi-asserted-by":"publisher","first-page":"454S","DOI":"10.1378\/chest.08-0658","volume":"133","author":"C Kearon","year":"2008","unstructured":"Kearon C et al (2008) Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 133(6 Suppl):454S\u2013545S","journal-title":"Chest"},{"issue":"2 Suppl","key":"2089_CR6","doi-asserted-by":"publisher","first-page":"e419S","DOI":"10.1378\/chest.11-2301","volume":"141","author":"C Kearon","year":"2012","unstructured":"Kearon C et al (2012) Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 141(2 Suppl):e419S\u2013e496S","journal-title":"Chest"},{"key":"2089_CR7","unstructured":"National CGCU (2012) Venous thromboembolic diseases: the management of venous thromboembolic diseases and the role of thrombophilia testing"},{"issue":"2","key":"2089_CR8","first-page":"111","volume":"32","author":"AN Nicolaides","year":"2013","unstructured":"Nicolaides AN et al (2013) Prevention and treatment of venous thromboembolism\u2013International Consensus Statement. Int Angiol 32(2):111\u2013260","journal-title":"Int Angiol"},{"issue":"2","key":"2089_CR9","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.chest.2015.11.026","volume":"149","author":"C Kearon","year":"2016","unstructured":"Kearon C et al (2016) Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest 149(2):315\u2013352","journal-title":"Chest"},{"issue":"7\u20138","key":"2089_CR10","doi-asserted-by":"crossref","first-page":"410","DOI":"10.20452\/pamw.2353","volume":"124","author":"A Rabinovich","year":"2014","unstructured":"Rabinovich A, Kahn SR (2014) How to predict and diagnose postthrombotic syndrome. Pol Arch Med Wewn 124(7\u20138):410\u2013416","journal-title":"Pol Arch Med Wewn"},{"key":"2089_CR11","volume-title":"The practice of statistics","author":"D Yates","year":"1999","unstructured":"Yates D, Moore D, McCabe G (1999) The practice of statistics. W. H. Freeman, New York"},{"key":"2089_CR12","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.thromres.2018.09.056","volume":"173","author":"S Barco","year":"2019","unstructured":"Barco S et al (2019) Impact of sex, age, and risk factors for venous thromboembolism on the initial presentation of first isolated symptomatic acute deep vein thrombosis. Thromb Res 173:166\u2013171","journal-title":"Thromb Res"},{"issue":"12","key":"2089_CR13","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1111\/j.1538-7836.2009.03629.x","volume":"7","author":"JP Galanaud","year":"2009","unstructured":"Galanaud JP et al (2009) Comparison of the clinical history of symptomatic isolated distal deep-vein thrombosis vs. proximal deep vein thrombosis in 11 086 patients. J Thromb Haemost 7(12):2028\u20132034","journal-title":"J Thromb Haemost"},{"issue":"4","key":"2089_CR14","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1177\/0003319706290745","volume":"57","author":"F Ferrara","year":"2006","unstructured":"Ferrara F et al (2006) Optimal duration of treatment in surgical patients with calf venous thrombosis involving one or more veins. Angiology 57(4):418\u2013423","journal-title":"Angiology"},{"issue":"4","key":"2089_CR15","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/jth.12512","volume":"12","author":"JP Galanaud","year":"2014","unstructured":"Galanaud JP et al (2014) Incidence and predictors of venous thromboembolism recurrence after a first isolated distal deep vein thrombosis. J Thromb Haemost 12(4):436\u2013443","journal-title":"J Thromb Haemost"},{"issue":"6","key":"2089_CR16","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1177\/1358863X17720531","volume":"22","author":"MP Donadini","year":"2017","unstructured":"Donadini MP et al (2017) Long-term recurrence of venous thromboembolism after short-term treatment of symptomatic isolated distal deep vein thrombosis: a cohort study. Vasc Med 22(6):518\u2013524","journal-title":"Vasc Med"},{"issue":"6","key":"2089_CR17","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1111\/jth.13677","volume":"15","author":"L Franco","year":"2017","unstructured":"Franco L et al (2017) Anticoagulation in patients with isolated distal deep vein thrombosis: a meta-analysis. J Thromb Haemost 15(6):1142\u20131154","journal-title":"J Thromb Haemost"},{"issue":"3","key":"2089_CR18","first-page":"677","volume":"102","author":"M Monreal","year":"1992","unstructured":"Monreal M et al (1992) Deep venous thrombosis and the risk of pulmonary embolism. A systematic study. Chest 102(3):677\u2013681","journal-title":"Chest"},{"issue":"12","key":"2089_CR19","doi-asserted-by":"publisher","first-page":"e556","DOI":"10.1016\/S2352-3026(16)30131-4","volume":"3","author":"M Righini","year":"2016","unstructured":"Righini M et al (2016) Anticoagulant therapy for symptomatic calf deep vein thrombosis (CACTUS): a randomised, double-blind, placebo-controlled trial. Lancet Haematol 3(12):e556\u2013e562","journal-title":"Lancet Haematol"},{"issue":"5","key":"2089_CR20","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.jvs.2010.05.094","volume":"52","author":"T Schwarz","year":"2010","unstructured":"Schwarz T et al (2010) Therapy of isolated calf muscle vein thrombosis: a randomized, controlled study. J Vasc Surg 52(5):1246\u20131250","journal-title":"J Vasc Surg"},{"issue":"7","key":"2089_CR21","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1097\/00001721-200110000-00014","volume":"12","author":"T Schwarz","year":"2001","unstructured":"Schwarz T et al (2001) Therapy of isolated calf muscle vein thrombosis with low-molecular-weight heparin. Blood Coagul Fibrinolysis 12(7):597\u2013599","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"5","key":"2089_CR22","first-page":"1063","volume":"104","author":"G Palareti","year":"2010","unstructured":"Palareti G et al (2010) Evolution of untreated calf deep-vein thrombosis in high risk symptomatic outpatients: the blind, prospective CALTHRO study. Thromb Haemost 104(5):1063\u20131070","journal-title":"Thromb Haemost"},{"key":"2089_CR23","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.thromres.2016.11.009","volume":"149","author":"H Robert-Ebadi","year":"2017","unstructured":"Robert-Ebadi H, Righini M (2017) Management of distal deep vein thrombosis. Thromb Res 149:48\u201355","journal-title":"Thromb Res"},{"issue":"12","key":"2089_CR24","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1182\/blood-2013-10-512616","volume":"123","author":"G Palareti","year":"2014","unstructured":"Palareti G (2014) How I treat isolated distal deep vein thrombosis (IDDVT). Blood 123(12):1802\u20131809","journal-title":"Blood"},{"issue":"3","key":"2089_CR25","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1111\/jth.14700","volume":"18","author":"SK Poudel","year":"2020","unstructured":"Poudel SK et al (2020) Clinical outcomes of isolated distal deep vein thrombosis versus proximal venous thromboembolism in cancer patients: The Cleveland Clinic experience. J Thromb Haemost 18(3):651\u2013659","journal-title":"J Thromb Haemost"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-020-02089-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-020-02089-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-020-02089-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T11:42:57Z","timestamp":1722598977000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-020-02089-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,18]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["2089"],"URL":"https:\/\/doi.org\/10.1007\/s11239-020-02089-5","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,18]]},"assertion":[{"value":"18 March 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors state that they have no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}